Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection
2020 · Journal of Translational Medicine · 37 citations
https://doi.org/10.1186/s12967-020-02433-6
A
Azadeh Nasrazadani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
745
Citations
15
h-index
19
i10-index
Azadeh Nasrazadani is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies. The author has an h-index of 15, co-authored 70 publications.
ORCID: 0000-0003-0401-9342Papers by this author
worksThe Evolving Landscape of HER2-Directed Breast Cancer Therapy
2020 · Current Treatment Options in Oncology · 29 citations
https://doi.org/10.1007/s11864-020-00780-6
Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasis
2020 · Future Oncology · 27 citations
https://doi.org/10.2217/fon-2019-0719
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
2022 · The Lancet Healthy Longevity · 23 citations
https://doi.org/10.1016/s2666-7568(21)00280-4
CDK4/6 inhibitors: taking the place of chemotherapy?
2019 · The Lancet Oncology · 4 citations
https://doi.org/10.1016/s1470-2045(19)30507-8
Doxorubicin induced tongue hyperpigmentation
2022 · Current Problems in Cancer Case Reports · 4 citations
https://doi.org/10.1016/j.cpccr.2022.100147
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat